Document Classification

Section Type: METHODS

Text: Eligible patients received the following treatments : A (control), four cycles of mitomycin (8 mg/m (2) on day 1) / vindesine (3 mg/m (2) on days 1, 8) / cisplatin (80 mg/m (2) on day 1) plus TRT 60 Gy (treatment break for 1 week) ; B, weekly irinotecan (20 mg/m (2)) / carboplatin (area under the plasma concentration-time curve [AUC] 2) for 6 weeks plus TRT 60 Gy, followed by two courses of irinotecan (50 mg/m (2) on days 1, 8) / carboplatin (AUC 5 on day 1) ; C, weekly paclitaxel (40 mg/m (2)) / carboplatin (AUC 2) for 6 weeks plus TRT 60 Gy, followed by two courses of paclitaxel (200 mg/m (2) on day 1) / carboplatin (AUC 5 on day 1).